New Mexico Register / Volume
XXXIV, Issue 19 / October 10, 2023
This is an amendment to 16.19.29 NMAC,
Section 7 and 8, effective 10/10/2023.
Subsections A through E and G through N of 16.19.29.7 NMAC
were not published, as there are no changes. Subsections A and C through D of
16.19.29.8 NMAC were not published, as there are no changes.
16.19.29.7 DEFINITIONS:
***
F. “Drug of concern” means a non-controlled dangerous drug that the Board has by rule determined to require dispenser PMP reporting of in the same manner as controlled substance prescription dispensing, when required reporting is expected to protect patients due to interaction of the drug of concern with controlled substances or other compelling issue. Gabapentin is a drug of concern, except when dispensed pursuant to a prescription issued by a veterinarian.
***
[16.19.29.7 NMAC - N, 07/15/2004; A, 06/11/2011; A, 08/31/2012; A,
10/24/2014; A, 03/22/2015; A, 11/27/2016; A, 09/25/2018; A, 2/28/2023, A
10/10/2023]
16.19.29.8 MANDATORY
REPORTING OF PRESCRIPTION INFORMATION TO THE PMP:
***
B. Each dispenser
shall submit to the board by electronic means information regarding each
prescription dispensed for a drug included under Subsection A of this
section. Information to be submitted for
each prescription as well as the standards for how this information shall be
formatted, not contrary to law, is defined in the PMP data reporting manual
available on the state PMP website at http://nmpmp.[org] info
shall include at a minimum:
(1) dispenser
NPI number;
(2) dispenser
NCPDP number;
(3) dispenser
DEA number (unless no controlled substances are dispensed
and dispenser has no DEA number);
(4) patient
name;
(5) patient
address;
(6) patient
date of birth;
(7) patient
gender;
(8) reporting
status (new, revised, void);
(9) prescription
number;
(10) date
prescription written;
(11) refills
authorized;
(12) date
prescription filled;
(13) refill
number;
(14) product
ID (NDC) + product ID qualifier;
(15) quantity
dispensed;
(16) days’
supply;
(17) drug
dosage units;
(18) transmission
form of Rx origin;
(19) payment
type;
(20) prescriber
NPI number; (except veterinarians)
(21) prescriber
DEA number (unless prescriber is prescribing a drug of concern and has
no DEA number)
***
[16.19.29.8 NMAC - N, 07/15/2004; A, 06/11/2011; A, 08/31/2012; A,
03/22/2015; A, 03/23/2016; A, 09/25/2018; A, 2/28/2023; A 10/10/2023]